Lithuanian Laboratory Implementation Guide
0.0.1 - ci-build Lithuania vėliava

Lithuanian Laboratory Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-lab/ and changes regularly. See the Directory of published versions

Table of Contents

Dabartiniam puslapiui nėra vertimo puslapio, todėl jis pateiktas numatytąja kalba

.. 0 Table of Contents
... 1 Home
... 2 Examples
... 3 Pathology Report
... 4 Pathology Workflow
... 5 Profiles
... 6 Terminology
... 7 Artifacts Summary
.... 7.1 Apolipoprotein B
.... 7.2 Cholesterol HDL
.... 7.3 Cholesterol LDL
.... 7.4 Cholesterol LDL Method
.... 7.5 Cholesterol Non-HDL
.... 7.6 Cholesterol Total
.... 7.7 Glucose in Venous Blood
.... 7.8 High-sensitivity CRP
.... 7.9 Lipidogram (Lipid Panel – Serum or Plasma)
.... 7.10 Lipoprotein(a)
.... 7.11 Lipoprotein(a) Method
.... 7.12 Triglycerides
.... 7.13 ALT (GPT)
.... 7.14 ALT (GPT) Method
.... 7.15 AST (GOT)
.... 7.16 AST (GOT) Method
.... 7.17 Potassium
.... 7.18 HbA1c. Glycated Hemoglobin Test
.... 7.19 Albumin/Creatinine Ratio (ACR)
.... 7.20 Creatinine Test
.... 7.21 eGFR
.... 7.22 Observation: Lab - eGFR
.... 7.23 Composition: Pathology Document (LT Lab)
.... 7.24 Condition: Prostate Cancer
.... 7.25 Observation: Her2 Receptor Status
.... 7.26 Observation: Radiation Dose (LT Lab)
.... 7.27 Pathology Procedure
.... 7.28 Procedure: Biopsy (LT Lab)
.... 7.29 ServiceRequest: Pathology Order (Lt)
.... 7.30 ServiceRequest: Pathology Report (Lt)
.... 7.31 Observation: Specimen Adequacy
.... 7.32 Observation: Specimen Measurement
.... 7.33 Observation: Tumor Measurement
.... 7.34 Observation: Tumor Observable
.... 7.35 Specimen (LT Lab)
.... 7.36 Specimen: Tissue Block
.... 7.37 Substance: Specimen Additive (LT Lab)
.... 7.38 Observation: Estrogen Receptor Status
.... 7.39 Observation: HER2 FISH/CISH/SISH Molecular Test
.... 7.40 Observation: Ki-67 Proliferation Index
.... 7.41 Observation: Progesterone Receptor Status
.... 7.42 Specimen reciever
.... 7.43 Cervical Tumor Stage pN
.... 7.44 Cervical Tumor Stage pT
.... 7.45 HER2 FISH/CISH/SISH Result Classification (VS)
.... 7.46 HER2 IHC Score (VS)
.... 7.47 Her2 Receptor Statuses
.... 7.48 Histological Grading
.... 7.49 ICD-O-3 Morphology
.... 7.50 IHC Expression Level (VS)
.... 7.51 Lymphovascular Invasion
.... 7.52 Pathology Service Code
.... 7.53 Perineural Invasion
.... 7.54 Periprostatic Fat Invasion
.... 7.55 pLVI Classification (VS)
.... 7.56 Prostate Tumor Stage M
.... 7.57 Prostate Tumor Stage N
.... 7.58 Prostate Tumor Stage T
.... 7.59 Sample Examination Methods
.... 7.60 Seminal Vesicle Invasion
.... 7.61 Specimen Additive
.... 7.62 Specimen Adequacy Code
.... 7.63 Tumor Focality
.... 7.64 Tumor Type
.... 7.65 Tumor Volume Methodology
.... 7.66 HER2 FISH/CISH/SISH Result Classification
.... 7.67 HER2 IHC Score
.... 7.68 Her2 Receptor Status
.... 7.69 IHC Expression Level
.... 7.70 Lithuanian UCUM localisation
.... 7.71 pLVI Classification
.... 7.72 Tumor Observable Component Codes (LT Lab)
.... 7.73 Composition: Pathology Document (example)
.... 7.74 Condition: Prostate Cancer (example)
.... 7.75 DiagnosticReport: Pathology Report (example)
.... 7.76 Observation: ACR (example)
.... 7.77 Observation: Cholesterol HDL (example)
.... 7.78 Observation: Cholesterol LDL (example)
.... 7.79 Observation: Cholesterol Non-HDL (example)
.... 7.80 Observation: Creatinine Test (example)
.... 7.81 Observation: eGFR (example)
.... 7.82 Observation: Estrogen Receptor Status (example)
.... 7.83 Observation: Glucose Venous (example)
.... 7.84 Observation: Gram Stain (example)
.... 7.85 Observation: HbA1c (example)
.... 7.86 Observation: HER2 FISH Molecular Test (example)
.... 7.87 Observation: Her2 Receptor Status (example)
.... 7.88 Observation: Ki-67 Proliferation Index (example)
.... 7.89 Observation: Lipidogram (example)
.... 7.90 Observation: Progesterone Receptor Status (example)
.... 7.91 Observation: Prostate PSA (example)
.... 7.92 Observation: Prostate PSA Density (example)
.... 7.93 Observation: Prostate Volume (example)
.... 7.94 Observation: Specimen Adequacy (example)
.... 7.95 Observation: Specimen Measurement (example)
.... 7.96 Observation: Total Cholesterol (example)
.... 7.97 Observation: Triglycerides (example)
.... 7.98 Observation: Tumor Measurement (example)
.... 7.99 Observation: Tumor Observable (example)
.... 7.100 Organization: Vilnius Heart Clinic (example)
.... 7.101 Patient: Jonas Petrauskas (example)
.... 7.102 Practitioner: Registrar (example)
.... 7.103 Procedure: Breast Biopsy (example)
.... 7.104 Procedure: Histology (example)
.... 7.105 ServiceRequest: Pathology Order (example)
.... 7.106 ServiceRequest: Pathology Order — Prostate (example)
.... 7.107 Specimen Block: #A1 from Left Breast (example)
.... 7.108 Specimen: Left Breast Tissue (example)
.... 7.109 Specimen: Right Breast Tissue (example)
.... 7.110 Specimen: Venous Blood (example)
.... 7.111 Substance: Neutral Buffered Formalin (example)